NAVI
57
2
NOV
45
3
ROK
48
2
LUV
29
-4
TROW
34
2
RSG
57
-7
URBN
32
2
ORCL
73
-4
FIS
51
-2
NDAQ
59
-3
ECL
72
-2
THC
58
-4
F
47
3
COF
58
5
TSCO
57
-3
TMO
58
-2
EXC
54
-2
KLAC
59
2
PNW
66
-3
RHI
52
2
NAVI
57
2
NOV
45
3
ROK
48
2
LUV
29
-4
TROW
34
2
RSG
57
-7
URBN
32
2
ORCL
73
-4
FIS
51
-2
NDAQ
59
-3
ECL
72
-2
THC
58
-4
F
47
3
COF
58
5
TSCO
57
-3
TMO
58
-2
EXC
54
-2
KLAC
59
2
PNW
66
-3
RHI
52
2
Financhill
Back

Assa Abloy AB 10K Form

Buy
65

ASAZY
Assa Abloy AB

Last Price:
16.19
Seasonality Move:
5.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASAZY News And Ratings

See the #1 stock for the next 7 days that we like better than ASAZY

ASAZY Financial Statistics

Sales & Book Value

Annual Sales: $13.29B
Cash Flow: $408.61M
Price / Cash Flow: 22.03
Annual Sales: $4.25
Price / Book: 3.85

Profitability

EPS (TTM): 0.62440
Net Income (TTM): $1.39B
Gross Margin: $5.34B
Return on Equity: 15.29%
Return on Assets: 7.12%

Assa Abloy AB Earnings Forecast

Key Assa Abloy AB Financial Ratios

  • The Gross Profit Margin over the past 28 years for ASAZY is 40.15%.
  • The Selling, General & Administrative Expenses for ASAZY have been equal to 20.57% of Gross Profit Margin.
  • The Research & Development expenses have been 4.06% of Revenue.
  • The Interest Expense is 18.51% of Operating Income.
  • The Net Earning history of ASAZY is 9.69% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 15 years.

Assa Abloy AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Building Products
Sector: Industrials
Current Symbol: ASAZY
Website: assaabloy.com

Debt

Debt-to-Equity Ratio: 0.65
Current Ratio: 1.1
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 28.17
Forward P/E Ratio: 0

ASAZY Technical Analysis vs Fundamental Analysis

Buy
65
Assa Abloy AB (ASAZY) is a Buy

Is Assa Abloy AB a Buy or a Sell?

  • Assa Abloy AB stock is rated a Buy
    The current Assa Abloy AB [ASAZY] share price is $16.32. The Score for ASAZY is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.